DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Compositions comprising HIV envelopes to induce CH235 lineage antibodies

Abstract

In certain aspects the invention provides HIV-1 immunogens, including HIV-1 envelope selections from individual CH505, and methods for swarm immunizations using combinations of HIV-1 envelopes.

Inventors:
; ; ; ; ;
Issue Date:
Research Org.:
Los Alamos National Laboratory (LANL), Los Alamos, NM (United States); Duke Univ., Durham, NC (United States)
Sponsoring Org.:
USDOE; National Institutes of Health (NIH)
OSTI Identifier:
1823803
Patent Number(s):
10968255
Application Number:
16/081,581
Assignee:
Duke University (Durham, NC); Triad National Security, LLC (Los Alamos, NM)
Patent Classifications (CPCs):
A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61K - PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
C - CHEMISTRY C07 - ORGANIC CHEMISTRY C07K - PEPTIDES
DOE Contract Number:  
AC52-06NA25396; AI100645
Resource Type:
Patent
Resource Relation:
Patent File Date: 03/01/2017
Country of Publication:
United States
Language:
English

Citation Formats

Haynes, Barton F., Bonsignori, Mattia, Liao, Hua-Xin, Korber, Bette T., Hraber, Peter T., and Saunders, Kevin. Compositions comprising HIV envelopes to induce CH235 lineage antibodies. United States: N. p., 2021. Web.
Haynes, Barton F., Bonsignori, Mattia, Liao, Hua-Xin, Korber, Bette T., Hraber, Peter T., & Saunders, Kevin. Compositions comprising HIV envelopes to induce CH235 lineage antibodies. United States.
Haynes, Barton F., Bonsignori, Mattia, Liao, Hua-Xin, Korber, Bette T., Hraber, Peter T., and Saunders, Kevin. Tue . "Compositions comprising HIV envelopes to induce CH235 lineage antibodies". United States. https://www.osti.gov/servlets/purl/1823803.
@article{osti_1823803,
title = {Compositions comprising HIV envelopes to induce CH235 lineage antibodies},
author = {Haynes, Barton F. and Bonsignori, Mattia and Liao, Hua-Xin and Korber, Bette T. and Hraber, Peter T. and Saunders, Kevin},
abstractNote = {In certain aspects the invention provides HIV-1 immunogens, including HIV-1 envelope selections from individual CH505, and methods for swarm immunizations using combinations of HIV-1 envelopes.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2021},
month = {4}
}

Works referenced in this record:

Mosaic clade M human immunodeficiency virus type 1 (HIV-1) envelope immunogens
patent, May 2011


Polyvalent, primary HIV-1 glycoprotein DNA vaccines and vaccination method
patent-application, July 2011


HIV-1 envelope glycoprotein
patent, November 2013